Phase 2, Multi-Center, Double-Blind, Randomized, 2-Arm, Parallel Study to Assess the Efficacy and Safety of Ryanodex (EGL-4104) as Adjuvant Treatment in Subjects with Exertional Heat Stroke (EHS)
2020-07-04
عنوان الدراسة
Phase 2, Multi-Center, Double-Blind, Randomized, 2-Arm, Parallel Study to Assess the Efficacy and Safety of Ryanodex (EGL-4104) as Adjuvant Treatment in Subjects with Exertional Heat Stroke (EHS)
داعم الدراسة
Eagle Pharmaceuticals
دواء الدراسة
Dantrolene
رقم بروتوكول الدراسة
EGL-4104-C-1801
حالة الدراسة
Ongoing
موقع الدراسة
King Faisal General Hospital (Makkah), Mina Al-Jisr Hospital, Mina Al-Wadi Hospital, Mina Al-Shari' Al-Jadid Hospital
مرحلة الدراسة
2
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。